Build **LiverGuard AI**—a $40K/year **Healthtech SaaS + precision agriculture platform** that **enables personalized, contaminant-free coffee blends for liver health**. The platform would: (1) Deploy **‘CropIQ’**: IoT sensors + edge AI (Raspberry Pi) to monitor coffee farms for mycotoxins/pesticides (e.g., ‘Farm #XYZ: 98% mycotoxin-free—certify’); (2) Provide **‘BlendEngine’**: AI-driven formulation tool generating personalized blends based on genetic/biometric data (e.g., ‘User #ABC: CYP1A2 slow metabolizer—reduce caffeine by 30%’); (3) Integrate with **‘DTC APIs’** (e.g., Shopify, Amazon) to auto-ship blends (e.g., ‘Monthly subscription: $49—deliver’); (4) Offer **‘Clinical Dashboard’**: Real-time liver biomarker tracking (e.g., ‘ALT levels: -20%—adjust blend’); (5) Include **‘FDA/EMA Compliance Engine’**: Auto-generates regulatory filings (e.g., ‘FDA GRAS: 100% compliant—submit’).

Coffee’s hepatoprotective effects (e.g., chlorogenic acid, caffeine) are well-documented, but: (1) **Lack of standardized dosing** leads to variability in efficacy (e.g., ‘Is 5 cups/day safe for everyone?’); (2) **Contamination risks** (mycotoxins, pesticides) in mass-market coffee undermine health benefits; (3) **No personalized formulations** for individuals with genetic predispositions (e.g., CYP1A2 slow metabolizers); (4) **Regulatory gaps** in functional coffee labeling (e.g., ‘liver-protective’ claims require FDA/EMA approval). The cost of inaction: $60B/year in preventable liver disease treatments (WHO, 2026) and lost productivity.